Arash Zare-Sadeghi

Dr. Arash Zare-Sadeghi

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Journal of Chemical Neuroanatomy
Verified
Journal Article
Closed access
نAنفیسه Alizadeh
نفیسه Alizadeh
ZBZohreh Bagher
Zohreh Bagher
SKSeyed Kamran Kamrava
Seyed Kamran Kamrava
MFMasoumeh Falah
Masoumeh Falah
HHHatef Ghasemi Hamidabadi
Hatef Ghasemi Hamidabadi
AKAli Komeili
Ali Komeili

1 October 2018 in Journal of Chemical Neuroanatomy
Verified
Journal Article
Closed access
ZBZohreh Bagher
Zohreh Bagher
SKSeyed Kamran Kamrava
Seyed Kamran Kamrava
نAنفیسه Alizadeh
نفیسه Alizadeh
MFMohammad Farhadi
Mohammad Farhadi
MAMoloud Absalan
Moloud Absalan
AKAli Komeili
Ali Komeili

1 June 2022 in Journal Of Neuroradiology
Verified
Journal Article
Closed access
ARAbolhasan Rezaeyan
Abolhasan Rezaeyan
SASomayeh Asadi
Somayeh Asadi
SKS. Kamran Kamrava
S. Kamran Kamrava
SKSamideh Khoei
Samideh Khoei
AZArash Zare-Sadeghi
Arash Zare-Sadeghi

4 February 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
FMFatemeh Mohammadian
Fatemeh Mohammadian
MNMaryam Noroozian
Maryam Noroozian
AZArash Zare-Sadeghi
Arash Zare-Sadeghi
VMVahid Malekian
Vahid Malekian
ASAzam Saffar
Azam Saffar
HRHamidreza Saligheh Rad
Hamidreza Saligheh Rad
(1) Background: Alzheimer’s disease (AD) is a neurodegenerative disease with a high prevalence. Despite the cognitive tests to diagnose AD, there are pitfalls in early diagnosis. Brain deposition of pathological markers of AD can affect the direction and intensity of the signaling. The study of effective connectivity allows the evaluation of intensity flow and signaling pathways in functional regions, even in the early stage, known as amnestic mild cognitive impairment (aMCI). (2) Methods: 16 aMCI, 13 AD, and 14 normal subjects were scanned using resting-state fMRI and T1-weighted protocols. After data pre-processing, the signal of the predefined nodes was extracted, and spectral dynamic causal modeling analysis (spDCM) was constructed. Afterward, the mean and standard deviation of the Jacobin matrix of each subject describing effective connectivity was calculated and compared. (3) Results: The maps of effective connectivity in the brain networks of the three groups were different, and the direction and strength of the causal effect with the progression of the disease showed substantial changes. (4) Conclusions: Impaired information flow in the resting-state networks of the aMCI and AD groups was found versus normal groups. Effective connectivity can serve as a potential marker of Alzheimer’s pathophysiology, even in the early stages of the disease.

6 January 2023 in Journal Of Neuroradiology
Verified
Journal Article
Closed access
ARAbolhasan Rezaeyan
Abolhasan Rezaeyan
SASomayeh Asadi
Somayeh Asadi
SKS. Kamran Kamrava
S. Kamran Kamrava
AZArash Zare-Sadeghi
Arash Zare-Sadeghi

1 March 2019 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
AFAli Farashahi
Ali Farashahi
AZArash Zare-Sadeghi
Arash Zare-Sadeghi
ASAli Shakeri-Zadeh
Ali Shakeri-Zadeh
SKS. Kamran Kamrava
S. Kamran Kamrava
SMShayan Maleki
Shayan Maleki
FFFariborz Faeghi
Fariborz Faeghi